Tasectan MDR Approved

GREAT NEWS! Noventure is delighted to announce that our medical device Tasectan has just been granted a new CЄ Certificate under MDR Regulation. 

With 3,7 Mio packs, equivalent to more than 51 Mio of standard units sold through our licensees in 34 countries during 2023, the Tasectan franchise is already a strong player in many markets. Now, its accumulated real-life experience, excellent safety record, and solid scientific backup have facilitated Tasectan to comply with the latest, stricter, European legislation regarding Medical Devices.

We are positive that, under the MDR certification, Tasectan will keep contributing to improving the GI well-being of many more patients, children and adults, in the years to come.

Learn more about Tasectan and other Noventure products at: Products | Noventure